About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 156 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 156 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 156 trials

SuspendedA Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.NCT04520412·Gilbert, Arizona and 170 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseThis is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to…NCT05531656·Birmingham, Alabama and 49 others

CompletedHome-based Transcranial Direct Current Stimulation for Pain Management in Persons With Alzheimer's Disease and Related DementiasThe purpose of this project is to evaluate the preliminary effects of home-based M1-SO applied tDCS (that is, tDCS with the anode over the primary motor cortex and the cathode…NCT04457973·Houston, Texas

RecruitingA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis…NCT06585787·Chandler, Arizona and 295 others

CompletedCholine Effects - Pre-symptomatic ADThe purpose of this study is to test the safety, tolerability, and effects of choline in people with increased risk of Alzheimer's Disease (AD), also known as pre-symptomatic AD.NCT05880849·Houston, Texas

CompletedA Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild ADThis Phase 1 study is a single ascending dose (SAD) and multiple ascending dose (MAD), placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and…NCT04931459·Scottsdale, Arizona and 16 others

TerminatedAD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseThe purpose of this study is to evaluate the effect of pioglitazone at 24 months compared with placebo on cognitive decline in high-risk participants who have completed the…NCT02284906·Phoenix, Arizona and 42 others

CompletedA Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseThis is a multinational, multicenter, double-blind, placebo-controlled, parallel-group study using a Bayesian design with response adaptive randomization across placebo or 5…NCT01767311·Birmingham, Alabama and 168 others

TerminatedStudy to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeThis study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for…NCT04464564·Phoenix, Arizona and 105 others

TerminatedStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's…NCT01969136·Tucson, Arizona and 80 others

TerminatedHome-based tDCS for Apathy in Alzheimer's DiseaseThe purpose of this study is to assess feasibility, acceptability, and safety of providing tDCS to Alzheimer's disease and related dementias (ADRD) patients with apathy and to…NCT04855643·Houston, Texas

Active not recruitingHead-to-Head Harmonization of Tau Tracers in Alzheimer's DiseaseThe purpose of this study is to compare/harmonize cross-sectional and longitudinal tau tangle measurements obtained with the tau PET radiopharmaceuticals Flortaucipir and MK-6240…NCT05361382·Berkeley, California and 8 others

CompletedNormative Database and Test-Retest Reliability for BrainCheck AssessmentsThe purpose of this study is to collect normative test values and demographic information for normative and referential data for a rapid, portable, computerized neurocognitive…NCT05497427·Palo Alto, California and 4 others

TerminatedA Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)This is an open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term administration of open-label gantenerumab in participants with…NCT04374253·Phoenix, Arizona and 267 others

CompletedAssessing Clinical Outcomes in Alzheimer's Disease AgitationThis is a multi-center, double-blind, placebo-controlled, randomized withdrawal study to evaluate the efficacy and safety of AXS-05 compared to placebo in the treatment of…NCT04797715·Sun City, Arizona and 62 others

CompletedSimufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsA two-year safety study of simufilam (PTI-125) 100 mg oral tablets twice daily for participants of the previous simufilam studies as wells as additional new mild-to-moderate…NCT04388254·Gilbert, Arizona and 16 others

Completed18F-AV-1451 Autopsy StudyThis study is designed to test the relationship between ante-mortem flortaucipir Positron Emission Tomography (PET) imaging and tau neurofibrillary pathology associated with…NCT02516046·Phoenix, Arizona and 30 others

CompletedP3 (Prepared, Protected, emPowered)P3 (Prepared, Protected, emPowered) is an interactive smartphone app for HIV-uninfected YMSM and YTW that utilizes social networking and game-based mechanics as well as a…NCT03320512·Tampa, Florida and 8 others

TerminatedAn Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of lanabecestat compared with placebo administered for 104 weeks in the treatment of early Alzheimer´s disease.NCT02245737·Phoenix, Arizona and 253 others

CompletedEfficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseThe goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.NCT00099242·Orange, California and 74 others

PreviousPage 5 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia